If you live in the U.S., or Canada and your child has incontinence due to Spina Bifida, Spinal Cord Injury, or Transverse Myelitis, you may be able to enroll your child in a clinical research study to test the effectiveness of an investigational medication. The hope is that this medication will one day be a treatment for urinary leakage in children and teenagers.
Your child may be eligible if they:
- Are 5-17 years of age
- Have bladder leakage
- Use clean intermittent catheterization
The study would require that you:
- Read and sign an informed consent form agreeing to participate in the study
- Visit the study doctor for a physical examination and assessment to determine whether the study is right for your child
- A second visit to the study doctor to receive the medication
- Completion of bladder diaries and questionnaires
- Follow up clinic visits and phone monitoring of your child’s health and response to medication
Why participate in this study?
- Your child will have access to a study team who will ensure that your child is monitored and that any questions or concerns are answered
- All study medication, study-related medical examinations, and lab tests will be provided at no cost
- Although there are no guarantees, this research could help your child and others have reduced urinary leakage
If interested in learning more about this study, you can download the study brochure here, visit http://allerganclinicaltrials.com, https://clinicaltrials.gov/show/NCT01852045, or e-mail firstname.lastname@example.org.
Note: The Spina Bifida Association (SBA) is working with Allergan to help make parents of children with Spina Bifida aware of this clinical research opportunity. SBA is not involved in or affiliated with this study in any way. Please direct questions to Allergan.